In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

Blood vessel changes in the eye mirror brain damage in mice with a gene variant linked to dementia, potentially offering ...

Memory loss is the tell-tale sign that you or a loved one could be developing dementia. However, science shows your eyes ...

Did you know your eyes can reveal diabetes, heart issues, or tumors? Discover which systemic diseases manifest through vision ...

Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...

Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...

MicroPort NeuroTech Limited ($HK:2172) announced an update on their ongoing clinical study. Study Overview The clinical study “a Prospective, ...

Invasive plants threaten the health of Eden Prairie’s parks and wild spaces, but volunteers are fighting back.

PreEvnt’s isaac system enters human clinical trials, bringing non-invasive, breath-based glucose monitoring closer to a late ...

For high-risk patients, the method could offer a safer alternative to open-heart surgery.

Diagnosing pancreatic cancer at an early stage is challenging. The signs and symptoms — including abdominal pain, weight loss and indigestion — are often non-specific and shared with benign diseases.

A team of researchers at the Massachusetts Institute of Technology (MIT) has used Raman spectroscopy to develop a shoebox-sized device that can measure blood glucose levels without any needles, MIT ...